Fig. 1From: Successful use of next generation genomic sequencing (NGS)-directed therapy of clear cell carcinoma of the ovary (CCCO) with trametinib and metformin in a patient with chemotherapy-refractory diseaseComparison of baseline (left) and post-treatment (right) PET scans (3D MIP images)Back to article page